FDA Update: Committees Recommend Approvals for Abuse-Deterrent Opioid & Brodalumab Michele B. Kaufman, PharmD, BCGP | August 17, 2016 FDA advisory committees recommend the approvals of the abuse-deterrent opioid morphine sulfate for pain and brodalumab for plaque psoriasis…